Ethical Compliance
SUVEN PHARMACEUTICALS
Sector:
Healthcare
Industry:
Drug Manufacturers - Specialty & Generic
Market Cap Class:
large
Revenue
0.2%
Debt
1.7%
Liquidity
2.2%
Revenue
Debt
Liquidity
0.2%
Non Compliant
Questionable
Compliant
Compliant
INR Crores
| Pharmaceutical Products | ₹987.65 |
| Sale of Services | ₹48.19 |
| Export Incentives | ₹6.25 |
| Duty Drawback Received | ₹9.26 |
| other income | ₹59.89 |
Questionable
INR Crores
Non Compliant
INR Crores
| interest & other | ₹2.02 |
INR Crores
| Revenue from Questionable Sources: | ₹0.00 |
| Revenue from Non Compliant Sources: | ₹2.02 |
| Total: | ₹2.02 |
| Total Revenue: | ₹1,113.26 |
Formula
Revenue from Questionable & Non Compliant Sources
Total Revenue
≤ 0.03 or 3%
Calculation
₹2.02
₹1,113.26
= 0.2%
compliant
Rationale
The sum of revenue from questionable and non-compliant sources should not exceed 3% of the total revenue. This ensures that the company has tolerable reliance on unethical sources of revenue.
